AAAAAA
Results: 1-25/28
Authors:
LUNDIN J
OSTERBORG A
BRITTINGER G
CROWTHER D
DOMBRET H
ENGERT A
EPENETOS A
GISSELBRECHT C
HUHN D
JAEGER U
THOMAS J
MARCUS R
NISSEN N
POYNTON C
RANKIN E
STAHEL R
UPPENKAMP M
WILLEMZE R
MELLSTEDT H
Citation: J. Lundin et al., CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3257-3263
Authors:
YI Q
EKMAN M
ANTON D
BERGENBRANT S
OSTERBORG A
GEORGIIHEMMING P
HOLM G
NILSSON K
BIBERFELD P
Citation: Q. Yi et al., BLOOD DENDRITIC CELLS FROM MYELOMA PATIENTS ARE NOT INFECTED WITH KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS (KSHV HHV-8)/, Blood, 92(2), 1998, pp. 402-404
Authors:
HELLSTROMLINDBERG E
AHLGREN T
BEGUIN Y
CARLSSON M
CARNESKOG J
DAHL IM
DYBEDAL I
GRIMFORS G
KANTERLEWENSOHN L
LINDER O
LUTHMAN M
LOFVENBERG E
NILSSONEHLE H
SAMUELSSON J
TANGEN JM
WINQVIST I
OBERG G
OSTERBORG A
OST A
Citation: E. Hellstromlindberg et al., TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS, Blood, 92(1), 1998, pp. 68-75
Authors:
OSTERBORG A
YI Q
HENRIKSSON L
FAGERBERG J
BERGENBRANT S
JEDDITEHRANI M
RUDEN U
LEFVERT AK
HOLM G
MELLSTEDT H
Citation: A. Osterborg et al., IDIOTYPE IMMUNIZATION COMBINED WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN MYELOMA PATIENTS INDUCED TYPE-I, MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED, CD8-SPECIFIC AND CD4-SPECIFIC T-CELL RESPONSES, Blood, 91(7), 1998, pp. 2459-2466
Authors:
OSTERBORG A
WERNER A
HALAPI E
LUNDIN J
HARMENBERG U
WIGZELL H
MELLSTEDT H
Citation: A. Osterborg et al., CLONAL CD8(-) T-CELLS ARE INDUCED IN RESPONDING B-CELL LYMPHOMA PATIENTS TREATED WITH CAMPATH-1H (ANTI-CD52)() AND CD52(), European journal of haematology, 58(1), 1997, pp. 5-13
PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors:
OSTERBORG A
DYER MJS
BUNJES D
PANGALIS GA
BASTION Y
CATOVSKY D
MELLSTEDT H
RANKIN E
TSEKOURAS C
PANGALIS GA
CAVALLI F
SESSA C
HUHN D
MARCUS R
MAUGHAN T
POYNTON C
NISSEN N
CARNEY D
BRITTINGER G
UPPENKAMP M
ELONEN E
TEERENHOVI L",ENGERT,"WILLEMZE R
KLUINNELEMANS J
THOMAS J
EPENETOS AA
NETHERSELL A
DYER M
CATOVSKY D
DICATO M
BASTION Y
COIFFIER B
RANADA JMF
CROWTHER D
WOLL P
RAEMAKAERS J
DEPAUW B
DEGOS L",GISSELLBRECHT,"REIFFERS J
MELLSTEDT H
FASSAS A
ANAGNOSTOPOULOS A
BUNJES D
JAEGER U
STAHEL RA
Citation: A. Osterborg et al., PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1567-1574
Authors:
HALAPI E
WERNER A
WAHLSTROM J
OSTERBORG A
JEDDITEHRANI M
YI Q
JANSON CH
WIGZELL H
GRUNEWALD J
MELLSTEDT H
Citation: E. Halapi et al., T-CELL REPERTOIRE IN PATIENTS WITH MULTIPLE-MYELOMA AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE - CLONAL CD8(-CELL EXPANSIONS ARE FOUND PREFERENTIALLY IN PATIENTS WITH A LOW TUMOR BURDEN() T), European Journal of Immunology, 27(9), 1997, pp. 2245-2252
Authors:
YI Q
ERIKSSON I
HE W
HOLM G
MELLSTEDT H
OSTERBORG A
Citation: Q. Yi et al., IDIOTYPE-SPECIFIC T-LYMPHOCYTES IN MONOCLONAL GAMMOPATHIES - EVIDENCEFOR THE PRESENCE OF CD4(+) AND CD8(+) SUBSETS, British Journal of Haematology, 96(2), 1997, pp. 338-345
Authors:
YI Q
DABADGHAO S
OSTERBORG A
BERGENBRANT S
HOLM G
Citation: Q. Yi et al., MYELOMA BONE-MARROW PLASMA-CELLS - EVIDENCE FOR THEIR CAPACITY AS ANTIGEN-PRESENTING CELLS, Blood, 90(5), 1997, pp. 1960-1967
Authors:
FOLKERS K
OSTERBORG A
NYLANDER M
MORITA M
MELLSTEDT H
Citation: K. Folkers et al., ACTIVITIES OF VITAMIN-Q(10) IN ANIMAL-MODELS AND A SERIOUS DEFICIENCYIN PATIENTS WITH CANCER, Biochemical and biophysical research communications, 234(2), 1997, pp. 296-299
Authors:
OSTERBORG A
Citation: A. Osterborg, NEW APPLICATIONS OF GM-CSF, Medical oncology, 13(3), 1996, pp. 3-3
Authors:
YI Q
OSTERBORG A
Citation: Q. Yi et A. Osterborg, IDIOTYPE-SPECIFIC T-CELLS IN MULTIPLE-MYELOMA - TARGETS FOR AN IMMUNOTHERAPEUTIC INTERVENTION, Medical oncology, 13(1), 1996, pp. 1-7
Authors:
YI Q
ERIKSSON I
HE W
MELLSTEDT H
HOLM G
OSTERBORG A
Citation: Q. Yi et al., IDIOTYPE-SPECIFIC CD4-CELL SUBSETS IN MONOCLONAL GAMMOPATHIES( AND CD8+ T), Experimental hematology, 24(9), 1996, pp. 708-708
Authors:
PEEST D
BLADE J
HAROUSSEAU JL
KLEIN B
OSTERBORG A
SANMIGUEL JF
Citation: D. Peest et al., CYTOKINE THERAPY IN MULTIPLE-MYELOMA, British Journal of Haematology, 94(3), 1996, pp. 425-432
HUMANIZED CD52 MONOCLONAL-ANTIBODY CAMPATH-1H AS FIRST-LINE TREATMENTIN CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors:
OSTERBORG A
FASSAS AS
ANAGNOSTOPOULOS A
DYER MJS
CATOVSKY D
MELLSTEDT H
Citation: A. Osterborg et al., HUMANIZED CD52 MONOCLONAL-ANTIBODY CAMPATH-1H AS FIRST-LINE TREATMENTIN CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 93(1), 1996, pp. 151-153
Authors:
BERGENBRANT S
YI Q
OSTERBORG A
BJORKHOLM M
OSBY E
MELLSTEDT H
Citation: S. Bergenbrant et al., MODULATION OF ANTIIDIOTYPIC IMMUNE-RESPONSE BY IMMUNIZATION WITH THE AUTOLOGOUS M-COMPONENT PROTEIN IN MULTIPLE-MYELOMA PATIENTS, British Journal of Haematology, 92(4), 1996, pp. 840-846
Authors:
ISAKSSON E
BJORKHOLM M
HOLM G
JOHANSSON B
NILSSON B
MELLSTEDT H
OSTERBORG A
Citation: E. Isaksson et al., BLOOD CLONAL B-CELL EXCESS IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) - ASSOCIATION WITH MALIGNANT TRANSFORMATION, British Journal of Haematology, 92(1), 1996, pp. 71-76
Authors:
OSTERBORG A
YI Q
HENRIKSSON L
FAGERBERG J
BERGENBRANT S
LEFVERT AK
HOLM G
MELLSTEDT H
Citation: A. Osterborg et al., IDIOTYPE IMMUNIZATION IN COMBINATION WITH GM-CSF OF MYELOMA PATIENTS INDUCED A CD8 T-CELL RESPONSE AND TUMOR-REGRESSION, Blood, 88(10), 1996, pp. 2329-2329
Authors:
KIMBY E
OSTERBORG A
MELLSTEDT H
Citation: E. Kimby et al., CLINICAL AND BIOLOGICAL EFFECTS OF INTERLEUKIN-4 (IL-4) IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA OF B-CELL TYPE (B-CLL), Blood, 88(10), 1996, pp. 2347-2347
Authors:
OSTERBORG A
BOOGAERTS MA
CIMINO R
ESSERS U
HOLOWIECKI J
JULIUSSON G
JAGER G
NAJMAN A
PEEST D
Citation: A. Osterborg et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT ANEMIC PATIENTS WITH MULTIPLE-MYELOMA AND NON-HODGKINS-LYMPHOMA - A RANDOMIZED MULTICENTER STUDY, Blood, 87(7), 1996, pp. 2675-2682
Authors:
SANGFELT O
OSTERBORG A
GRANDER D
ANDERBRING E
OST A
MELLSTEDT H
EINHORN S
Citation: O. Sangfelt et al., RESPONSE TO INTERFERON THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA CORRELATES WITH EXPRESSION OF THE BCL-2 ONCOPROTEIN, International journal of cancer, 63(2), 1995, pp. 190-192
IDIOTYPE-SPECIFIC T-CELLS IN MULTIPLE-MYELOMA STAGE-I - AN EVALUATIONBY 4 DIFFERENT FUNCTIONAL TESTS
Authors:
OSTERBORG A
YI Q
BERGENBRANT S
HOLM G
LEFVERT AK
MELLSTEDT H
Citation: A. Osterborg et al., IDIOTYPE-SPECIFIC T-CELLS IN MULTIPLE-MYELOMA STAGE-I - AN EVALUATIONBY 4 DIFFERENT FUNCTIONAL TESTS, British Journal of Haematology, 89(1), 1995, pp. 110-116
Authors:
YI Q
OSTERBORG A
BERGENBRANT S
MELLSTEDT H
HOLM G
LEFVERT AK
Citation: Q. Yi et al., IDIOTYPE-REACTIVE T-CELL SUBSETS AND TUMOR LOAD IN MONOCLONAL GAMMOPATHIES, Blood, 86(8), 1995, pp. 3043-3049
Authors:
BERGENBRANT S
YI Q
OSBY E
OSTERBORG A
OSTMAN R
BJORKHOLM M
HOLM G
LEFVERT AK
Citation: S. Bergenbrant et al., ANTIIDIOTYPIC B-LYMPHOCYTES IN PATIENTS WITH MONOCLONAL GAMMOPATHIES, Scandinavian journal of immunology, 40(2), 1994, pp. 216-220
Authors:
RAGNHAMMAR P
FRIESEN HJ
FRODIN JE
LEFVERT AK
HASSAN M
OSTERBORG A
MELLSTEDT H
Citation: P. Ragnhammar et al., INDUCTION OF ANTI-RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (ESCHERICHIA COLI-DERIVED) ANTIBODIES AND CLINICAL EFFECTS IN NONIMMUNOCOMPROMISED PATIENTS, Blood, 84(12), 1994, pp. 4078-4087